AstraZeneca Pharmaceuticals LP will pay Washington state nearly $10 million for improperly marketing Seroquel, a drug used to treat schizophrenia and manic depression. Federal and state officials say that AstraZeneca illegally paid for doctors to attend meetings at resorts, where those doctors would “advise” the drug maker about marketing messages for unapproved uses.
U.S. health regulators have warned Pfizer Inc. over a series of failures that led to the overdosing of at least 13 children in a clinical trial of its antipsychotic drug Geodon, according to a letter made public on Tuesday.
Young people are being overmedicated and undermined. It is time that we recognize that the deluge of amphetamines and psychotropic drugs being consumed by teenagers may be more of a problem than a solution.
Sgt. Eric Layne’s death was not pretty. A few months after being prescribed a drug cocktail with the antidepressant Paxil, the mood stabilizer Klonopin and AstraZeneca’s controversial antipsychotic drug Seroquel, the Iraq war veteran was “suffering from incontinence, severe depression [and] continuous headaches,” according to his widow, Janette Layne, at FDA hearings for new Seroquel approvals last year.
The Massachusetts attorney general joined that federal lawsuit accusing Johnson & Johnson of paying kickbacks to push the antipsychotic Risperdal and other drugs into nursing homes. AG Martha Coakley didn’t stop there; however, her office is also investigating other companies that market antipsychotics to nursing homes in the state.